Vascular Endothelial-Specific Dimethylarginine Dimethylaminohydrolase-1-Deficient Mice Reveal That Vascular Endothelium Plays an Important Role in Removing Asymmetric Dimethylarginine

被引:71
作者
Hu, Xinli [1 ,2 ]
Xu, Xin [1 ,2 ]
Zhu, Guangshuo [1 ,2 ]
Atzler, Dorothee [3 ]
Kimoto, Masumi [4 ]
Chen, Ju [5 ]
Schwedhelm, Edzard [3 ]
Lueneburg, Nicole [3 ]
Boeger, Rainer H. [3 ]
Zhang, Ping [1 ,2 ]
Chen, Yingjie [1 ,2 ]
机构
[1] Univ Minnesota, Dept Med, Lillehei Heart Inst, Minneapolis, MN 55455 USA
[2] Univ Minnesota, Dept Med, Div Cardiol, Minneapolis, MN 55455 USA
[3] Univ Hosp Hamburg Eppendorf, Inst Expt & Clin Pharmacol, Clin Pharmacol Unit, Hamburg, Germany
[4] Okayama Prefectural Univ, Dept Nutr Sci, Okayama, Japan
[5] Univ Calif San Diego, Dept Med, San Diego, CA 92103 USA
基金
美国国家卫生研究院;
关键词
asymmetric dimethylarginine; dimethylarginine dimethylaminohydrolase; knockout mice; nitric oxide; METHYLARGININE METABOLISM; EXPRESSION; HEART; HYPERTENSION; DYSFUNCTION; ARGININE; ADMA; GENE; NG; NG-DIMETHYLARGININE; PURIFICATION;
D O I
10.1161/CIRCULATIONAHA.108.819912
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background-Asymmetrical methylarginines inhibit NO synthase activity and thereby decrease NO production. Dimethylarginine dimethylaminohydrolase 1 (DDAH1) degrades asymmetrical methylarginines. We previously demonstrated that in the heart DDAH1 is predominantly expressed in vascular endothelial cells. Because an earlier study showed that mice with global DDAH1 deficiency experienced embryonic lethality, we speculated that a mouse strain with selective vascular endothelial DDAH1 deficiency (endo-DDAH1(-/-)) would largely abolish tissue DDAH1 expression in many tissues but possibly avoid embryonic lethality. Methods and Results-By using the LoxP/Cre approach, we generated the endo-DDAH1(-/-) mice. The endo-DDAH1(-/-) mice had no apparent defect in growth or development compared with wild-type littermates. DDAH1 expression was greatly reduced in kidney, lung, brain, and liver, indicating that in these organs DDAH1 is distributed mainly in vascular endothelial cells. The endo-DDAH1(-/-) mice showed a significant increase of asymmetric dimethylarginine concentration in plasma (1.41 mu mol/L in the endo-DDAH1(-/-) versus 0.69 mu mol/L in the control mice), kidney, lung, and liver, which was associated with significantly increased systolic blood pressure (132 mm Hg versus 113 mm Hg in wild-type). The endo-DDAH1(-/-) mice also exhibited significantly attenuated acetylcholine-induced NO production and vessel relaxation in isolated aortic rings. Conclusions-Our study demonstrates that DDAH1 is highly expressed in vascular endothelium and that endothelial DDAH1 plays an important role in regulating blood pressure. In the context that asymmetric methylarginines are broadly produced by many type of cells, the strong DDAH1 expression in vascular endothelium demonstrates for the first time that vascular endothelium can be an important site to actively dispose of toxic biochemical molecules produced by other types of cells. (Circulation. 2009; 120: 2222-2229.)
引用
收藏
页码:2222 / U91
页数:11
相关论文
共 40 条
[1]   IMPLANTATION AND DECIDUALIZATION IN RODENTS [J].
ABRAHAMSOHN, PA ;
ZORN, TMT .
JOURNAL OF EXPERIMENTAL ZOOLOGY, 1993, 266 (06) :603-628
[2]   Asymmetric dimethylarginine causes hypertension and cardiac dysfunction in humans and is actively metabolized by dimethylarginine dimethylaminohydrolase [J].
Achan, V ;
Broadhead, M ;
Malaki, M ;
Whitley, G ;
Leiper, J ;
MacAllister, R ;
Vallance, P .
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY, 2003, 23 (08) :1455-1459
[3]   Metabolism of asymmetric dimethylarginines is regulated in the lung developmentally and with pulmonary hypertension induced by hypobaric hypoxia [J].
Arrigoni, FI ;
Vallance, P ;
Haworth, SG ;
Leiper, JM .
CIRCULATION, 2003, 107 (08) :1195-1201
[4]   Dimethylarginine dimethylaminohydrolase (DDAH) regulates trophoblast invasion and motility through effects on nitric oxide [J].
Ayling, L. J. ;
Whitley, G. St. J. ;
Aplin, J. D. ;
Cartwright, J. E. .
HUMAN REPRODUCTION, 2006, 21 (10) :2530-2537
[5]   Analysis of methylarginine metabolism in the cardiovascular system identifies the lung as a major source of ADMA [J].
Bulau, Patrick ;
Zakrzewicz, Dariusz ;
Kitowska, Kamila ;
Leiper, James ;
Gunther, Andreas ;
Grimminger, Friedrich ;
Eickelberg, Oliver .
AMERICAN JOURNAL OF PHYSIOLOGY-LUNG CELLULAR AND MOLECULAR PHYSIOLOGY, 2007, 292 (01) :L18-L24
[6]   Dimethylarginine dimethylaminohydrolase and endothelial dysfunction in failing hearts [J].
Chen, YJ ;
Li, YF ;
Zhang, P ;
Traverse, JH ;
Hou, MX ;
Xu, X ;
Kimoto, M ;
Bache, RJ .
AMERICAN JOURNAL OF PHYSIOLOGY-HEART AND CIRCULATORY PHYSIOLOGY, 2005, 289 (05) :H2212-H2219
[7]   Increased circulating concentrations of asymmetric dimethylarginine (ADMA) in white coat hypertension [J].
Çurgunlu, A ;
Uzun, H ;
Bavunoglu, I ;
Karter, Y ;
Genç, H ;
Vehid, S .
JOURNAL OF HUMAN HYPERTENSION, 2005, 19 (08) :629-633
[8]   Dimethylarginine dimethylaminohydrolase regulates nitric oxide synthesis - Genetic and physiological evidence [J].
Dayoub, H ;
Achan, V ;
Adimoolam, S ;
Jacobi, J ;
Stuehlinger, MC ;
Wang, BY ;
Tsao, PS ;
Kimoto, M ;
Vallance, P ;
Patterson, AJ ;
Cooke, JP .
CIRCULATION, 2003, 108 (24) :3042-3047
[9]   VASCULARIZATION OF THE MOUSE EMBRYO - A STUDY OF FLK-1, TEK, TIE, AND VASCULAR ENDOTHELIAL GROWTH-FACTOR EXPRESSION DURING DEVELOPMENT [J].
DUMONT, DJ ;
FONG, GH ;
PURI, MC ;
GRADWOHL, G ;
ALITALO, K ;
BREITMAN, ML .
DEVELOPMENTAL DYNAMICS, 1995, 203 (01) :80-92
[10]   Plasma levels of asymmetrical dimethyl-L-arginine in patients with congenital heart disease and pulmonary hypertension [J].
Gorenflo, M ;
Zheng, CB ;
Werle, E ;
Fiehn, W ;
Ulmer, HE .
JOURNAL OF CARDIOVASCULAR PHARMACOLOGY, 2001, 37 (04) :489-492